Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Alcohol-Induced Psychotic Disorder and Depressive Disorder: a Dual Diagnosis Case Series

https://doi.org/10.14412/2074-2711-2021-5-130-133

Full Text:

Abstract

Alcohol-induced psychotic disorder (AIPD) is a diagnosis in the ICD 10. Previous studies of AIPD do not appear to have reported the co-morbid presence of depressive disorder in either prevalence studies or treatment studies. Five cases are presented with a dual diagnosis of AIPD and depressive disorder. These cases were assessed using the Brief Psychiatric Rating Scale (BPRS), Hamilton Depression Rating Scale (HDRS), Clinical Global Impression Severity score (CGI-S), Clinical Global Impression Improvement score (CGI-I), Drug Attitude Inventory 10 (DAI 10), Short Assessment Personality-Abbreviated Scale (SAPAS) and Modified Sainsbury Tool. Antidepressants and antipsychotics were chosen based on drug attitude scores from DAI 10. Cases demonstrate inpatient and outpatient treatment with good treatment outcomes after six months. Three cases demonstrate suicide risk. The majority did not have a personality disorder. These cases highlight the importance of treating a depressive disorder in AIPD and of tailored medication treatments for poor medication compliance.

About the Authors

A. Elbelushi
Trinity College Dublin & Health Service Executive
Ireland

Trinity College Dublin, the University of Dublin, College Green, Dublin 2, D02 PN40



Z. Muravec
Trinity College Dublin & Health Service Executive
Ireland

Trinity College Dublin, the University of Dublin, College Green, Dublin 2, D02 PN40



H. Masood
Trinity College Dublin & Health Service Executive
Ireland

Trinity College Dublin, the University of Dublin, College Green, Dublin 2, D02 PN40



B. Masood
Trinity College Dublin & Health Service Executive
Ireland

Barkat Masood

Trinity College Dublin, the University of Dublin, College Green, Dublin 2, D02 PN40



References

1. World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. World Health Organization; 1992.

2. Glass IB. Alcoholic hallucinosis: a psychiatric enigma-1. The development of an idea. Br J Addict. 1989 Jan;84(1):29-41. doi: 10.1111/j.1360-0443.1989.tb00549.x

3. Glass IB. Alcoholic Hallucinosis: a psychiatric enigma-2. Follow-up Studies. Br J Addict. 1989 Feb;84(2):151-64. doi: 10.1111/j.1360-0443.1989.tb00564.x

4. Jordaan GP, Nel DG, Hewlett RH, Emsley R. Alcohol-induced psychotic disorder: a comparative study on the clinical characteristics of patients with alcohol dependence and schizophrenia. J Stud Alcohol Drugs. 2009 Nov;70(6):870-6. doi: 10.15288/jsad.2009.70.870

5. Narasimha VL, Patley R, Shukla L, et al. Phenomenology and course of alcoholic Hallucinosis. J Dual Diagn. 2019 Jul-Sep;15(3):172-6. doi: 10.1080/15504263.2019.1619008. Epub 2019 Jun 4.

6. Masood B, Lepping P, Romanov D, Poole R. Treatment of alcohol-induced psychotic disorder (alcoholic hallucinosis) A systematic review. Alcohol Alcohol. 2018 May 1;53(3):259-67. doi: 10.1093/alcalc/agx090

7. Sullivan LE, Fiellin DA, O'Connor PG. The prevalence and impact of alcohol problems in major depression: a systematic review. Am J Med. 2005 Apr;118(4):330-41. doi: 10.1016/j.amjmed.2005.01.007

8. Pettinati HM. Antidepressant treatment of co-occurring depression and alcohol dependence. Biol Psychiatry. 2004 Nov 15;56(10):785-92. doi: 10.1016/j.biopsych.2004.07.016

9. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale (BPRS): recent developments in ascertainment and scaling. Psychopharmacol Bull. 1988.

10. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960 Feb;23(1):56-62. doi: 10.1136/jnnp.23.1.56

11. Busner J, Targum SD. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont). 2007 Jul 1;4(7):28.

12. Moran P, Leese M, Lee T, et al. Standardised Assessment of Personality Abbreviated Scale (SAPAS): preliminary validation of a brief screen for personality disorder. Br J Psychiatry. 2003 Sep;183:228-32. doi: 10.1192/bjp.183.3.228

13. Hogan TP, Awad AG, Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med. 1983 Feb;13(1):177-83. doi: 10.1017/s0033291700050182

14. Stein W. Modified Sainsbury Tool: an initial risk assessment tool for primary care mental health and learning disability services. J Psychiatr Ment Health Nurs. 2005 Oct;12(5):620-33. doi: 10.1111/j.1365-2850.2005.00885.x

15. PerКlК J, Kuoppasalmi K, Pirkola S, et al. Alcohol-induced psychotic disorder and delirium in the general population. Br J Psychiatry. 2010 Sep;197(3):200-6. doi: 10.1192/bjp.bp.109.070797

16. Gordon AG. Otopathic voices and alcoholic visions. Irish J Psychol Med. 1998 Sep;15(3):110-1.

17. Cheer SM, Goa KL. Fluoxetine. Drugs. 2001;61(1):81-110. doi: 10.2165/00003495-200161010-00010

18. Smith DA, Beaumont K, Maurer TS, Di L. Relevance of Half-Life in Drug Design: Miniperspective. J Med Chem. 2018 May 24;61(10):4273-82. doi: 10.1021/acs.jmedchem.7b00969. Epub 2017 Nov 17.

19. Broder MS, Bates JA, Jing Y, et al. Association between second-generation antipsychotic medication half-life and hospitalization in the community treatment of adult schizophrenia. J Med Econ. 2012;15(1):105-11. doi: 10.3111/13696998.2011.632042. Epub 2011 Oct 28.

20. Hoy SM, Scott LJ, Keating GM. Intramuscular paliperidone palmitate. CNS Drugs. 2010 Mar;24(3):227-44. doi: 10.2165/11203810-000000000-00000

21. Attard A, Olofinjana O, Cornelius V, et al. Paliperidone palmitate long-acting injection prospective year-long follow-up of use in clinical practice. Acta Psychiatr Scand. 2014 Jul;130(1):46-51. doi: 10.1111/acps.12201. Epub 2013 Oct 1.

22. Taylor DM, Sparshatt A, O'Hagan M, Dzahini O. Effect of paliperidone palmitate on hospitalisation in a naturalistic cohort a four-year mirror image study. Eur Psychiatry. 2016 Sep;37:43-8. doi: 10.1016/j.eurpsy.2016.04.009. Epub 2016 Jul 20.

23. Maestri TJ, Mican LM, Rozea H, Barner JC. Do Long-Acting Injectable Antipsychotics Prevent or Delay Hospital Readmission? Psychopharmacol Bull. 2018 Mar 13;48(3):8.

24. George S, Chin CN. A 3 year case study of alcohol related psychotic disorders at Hospital Seremban. Med J Malaysia. 1998 Sep;53(3):223-6.

25. Muelas V. Alcoholic hallucinosis: response to treatment. Arch Neurobiol (Madr). 1990 Sep-Oct;53(5):192-5.

26. Benedetti, G. Die Alkoholhalluzinose. Stuttgart: Thieme; 1952.

27. Burton-Bradley BG. Aspects of alcoholic hallucinosis. Med J Aust. 1958 Jul 5;45(1):8-11. doi: 10.5694/j.1326-5377.1958.tb60543.x

28. Jordaan GP, Emsley R. Alcohol-induced psychotic disorder: a review. Metab Brain Dis. 2014 Jun;29(2):231-43. doi: 10.1007/s11011-013-9457-4. Epub 2013 Dec 5.

29. Soyka M, Raith L, Steinberg R. Mean age, sex ratio and psychopathology in alcohol psychoses. Psychopathology. 1988;21(1):19-25. doi: 10.1159/000284535

30. Victor M, Hope JM. The phenomenon of auditory hallucinations in chronic alcoholism. J Nerv Ment Dis. 1958 May;126(5):451-81. doi: 10.1097/00005053-195805000-00006

31. Ali IM, McBride AJ. Attendance rate in an alcohol problem clinic. Psychiatr Bull. 1997 Jun;21(6):343-5.

32. Soyka M, Helten B, Cleves M, Schmidt P. High rehospitalization rate in alcohol-induced psychotic disorder. Eur Arch Psychiatry Clin Neurosci. 2013 Jun;263(4):309-13. doi: 10.1007/s00406-012-0374-z. Epub 2012 Nov 1.


For citation:


Elbelushi A., Muravec Z., Masood H., Masood B. Alcohol-Induced Psychotic Disorder and Depressive Disorder: a Dual Diagnosis Case Series. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(5):130-133. https://doi.org/10.14412/2074-2711-2021-5-130-133

Views: 79


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)